Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.96B 4.59B 586M 506M 467M 437M 819M 55.69B 831M 5.53B 2.15B 27.09B 2.2B 2.15B 93.8B P/E Ratio 2026 *
8.71x
P/E Ratio 2027 * 7.73x
Enterprise Value 3.96B 4.59B 586M 506M 467M 437M 819M 55.69B 831M 5.53B 2.15B 27.09B 2.2B 2.15B 93.8B EV / Sales 2026 *
0.57x
EV / Sales 2027 * 0.52x
Free-Float
45.7%
Yield 2026 *
5.18%
Yield 2027 * 5.82%
05-26 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
04-27 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
03-30 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
03-27 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
03-27 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-06 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
01-13 Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Li Siu Bun from the Positions as an Independent Non-Executive Director, Chairman of the Audit Committee of the Board and A Member of Each of the Remuneration Committee of the Board and the Strategy and Planning Committee CI
12-30 Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
11-28 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective November 28, 2025 CI
11-28 Tong Ren Tang Technologies Co., Ltd. Enters into Supplemental Trademark Framework Agreement with Tong Ren Tang Holdings CI
11-28 Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Chen Fei as Non-Executive Director CI
25-10-28 Tong Ren Tang Technologies says 9m unaudited net profits attributable RMB416.26 million RE
25-09-30 Tong Ren Tang Technologies Renews Procurement, Sale Deals With Controlling Shareholder MT
1 day+0.28%
1 week+0.56%
Current month+1.70%
1 month-7.49%
3 months-16.55%
6 months-21.66%
Current year-18.82%
1 week 3.47
Extreme 3.47
3.67
1 month 3.41
Extreme 3.41
3.88
Current year 3.41
Extreme 3.41
4.56
1 year 3.41
Extreme 3.41
5.52
3 years 3.41
Extreme 3.41
7.8
5 years 3.41
Extreme 3.41
9.28
10 years 3.41
Extreme 3.41
16
Manager TitleAgeSince
Chief Executive Officer 58 2025-06-03
Compliance Officer 47 2025-11-27
Comptroller/Controller/Auditor 48 2025-06-03
Director TitleAgeSince
Director/Board Member 69 2018-06-11
Director/Board Member 65 2026-02-05
Director/Board Member 82 2018-06-11
Change 5-day change 1-year change 3-year change Capi.($)
+0.28%+0.56%-30.89%-48.86% 583M
+0.10%+4.12%-11.21%-3.71% 13.31B
+2.67%+0.40%-33.64%-55.67% 4.92B
+0.90%+3.87%-8.38%-1.94% 4.74B
+2.11%-3.36%+10.66%-20.14% 3.78B
+3.15%+3.56%+5.93%-41.49% 3.76B
+2.81%-1.45%-2.55%-8.26% 3.59B
+1.48%+2.49%-12.35%-4.51% 3.13B
+5.11%+2.56%-9.19%-28.61% 2.25B
+0.87%-2.57%-14.39%+25.48% 1.72B
Average +1.95%+1.13%-10.60%-18.77% 4.18B
Weighted average by Cap. +1.59%+1.65%-9.65%-15.73%

Financials

2026 *2027 *
Net sales 6.98B 8.09B 1.03B 893M 823M 770M 1.44B 98.19B 1.47B 9.76B 3.79B 47.77B 3.87B 3.79B 165B 7.56B 8.76B 1.12B 967M 891M 834M 1.56B 106B 1.59B 10.57B 4.1B 51.75B 4.2B 4.11B 179B
Net income 454M 527M 67.21M 58.11M 53.55M 50.13M 94.03M 6.39B 95.43M 635M 246M 3.11B 252M 247M 10.77B 514M 595M 75.94M 65.65M 60.5M 56.64M 106M 7.22B 108M 717M 278M 3.51B 285M 279M 12.16B
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,951
Date Price Change Volume
26-06-12 3.580 $ +0.28% 1,043,000
26-06-11 3.570 $ -1.65% 907,000
26-06-10 3.630 $ +3.71% 1,990,868
26-06-09 3.500 $ +0.29% 1,251,200
26-06-08 3.490 $ -1.97% 1,930,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
3.092CNY
Average target price
4.601CNY
Spread / Average Target
+48.82%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1666 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!